ATE219367T1 - Verfahren zur senkung des augeninnendrucks im auge von säugern unter anwendung von muskarinantagonisten - Google Patents

Verfahren zur senkung des augeninnendrucks im auge von säugern unter anwendung von muskarinantagonisten

Info

Publication number
ATE219367T1
ATE219367T1 AT93907541T AT93907541T ATE219367T1 AT E219367 T1 ATE219367 T1 AT E219367T1 AT 93907541 T AT93907541 T AT 93907541T AT 93907541 T AT93907541 T AT 93907541T AT E219367 T1 ATE219367 T1 AT E219367T1
Authority
AT
Austria
Prior art keywords
alpha
methyl
piperidinyl
dihydro
benzodiazepin
Prior art date
Application number
AT93907541T
Other languages
English (en)
Inventor
Mussie Elizabeth Wolde
Guadalupe Ruiz
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE219367T1 publication Critical patent/ATE219367T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT93907541T 1992-03-18 1993-03-16 Verfahren zur senkung des augeninnendrucks im auge von säugern unter anwendung von muskarinantagonisten ATE219367T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/853,374 US5716952A (en) 1992-03-18 1992-03-18 Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists
PCT/US1993/002403 WO1993018772A1 (en) 1992-03-18 1993-03-16 Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists

Publications (1)

Publication Number Publication Date
ATE219367T1 true ATE219367T1 (de) 2002-07-15

Family

ID=25315868

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93907541T ATE219367T1 (de) 1992-03-18 1993-03-16 Verfahren zur senkung des augeninnendrucks im auge von säugern unter anwendung von muskarinantagonisten

Country Status (8)

Country Link
US (1) US5716952A (de)
EP (1) EP0634932B1 (de)
JP (1) JPH07504915A (de)
AT (1) ATE219367T1 (de)
AU (1) AU666536B2 (de)
DE (1) DE69332048T2 (de)
ES (1) ES2177543T3 (de)
WO (1) WO1993018772A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000229961A (ja) * 1998-12-11 2000-08-22 Sagami Chem Res Center ヒドロナフト［２，３−ｃ］フラン誘導体およびその製造方法
US6063847A (en) * 1997-11-25 2000-05-16 Schering Corporation Thrombin receptor antagonists
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US6164282A (en) * 1999-01-27 2000-12-26 Allergan Sales, Inc. Methods for restoring and/or enhancing accommodation in pseudo phakia
BR0213967A (pt) * 2001-10-18 2005-08-30 Schering Corp Análogos de himbacina como antagonistas do receptor de trombina
US8466144B2 (en) 2004-07-16 2013-06-18 Proteosys Ag Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents
WO2010081825A2 (en) 2009-01-13 2010-07-22 Proteosys Ag Pirenzepine as an agent in cancer treatment
WO2012108841A1 (en) * 2011-02-09 2012-08-16 Singapore Health Services Pte. Ltd. Transglutaminase-2 inhibitors and uses thereof
WO2016172712A2 (en) * 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
EP3302426A4 (de) 2015-05-29 2018-12-05 Sydnexis, Inc. D2o-stabilisierte pharmazeutische formulierungen
US10251875B2 (en) 2017-05-11 2019-04-09 Nevakar Inc. Atropine pharmaceutical compositions
US20200345542A1 (en) * 2017-11-21 2020-11-05 Sydnexis, Inc. Ophthalmic composition and delivery device thereof
CN114302726A (zh) 2020-08-04 2022-04-08 参天制药株式会社 用于治疗近视、预防近视及/或抑制近视发展的药剂
WO2022080397A1 (ja) * 2020-10-14 2022-04-21 参天製薬株式会社 安定な医薬組成物
CN118946564A (zh) * 2022-03-30 2024-11-12 参天制药株式会社 高纯度化合物的制造方法及纯化方法
EP4501329A4 (de) 2022-03-30 2026-03-25 Santen Pharmaceutical Co Ltd Sterilisationsverfahren für pharmazeutische zubereitung und verpackung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2918407A (en) * 1957-04-08 1959-12-22 Lakeside Lab Inc Anti-spasmodics specific for upper gastrointestinal pain and spasm
US3467756A (en) * 1967-03-16 1969-09-16 Merck & Co Inc Composition and method for treating glaucoma
DE1795183B1 (de) * 1968-08-20 1972-07-20 Thomae Gmbh Dr K 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate und Arzneimittel
US4197301A (en) * 1978-10-16 1980-04-08 Allergan Pharmaceuticals, Inc. Topical ophthalmic use of Prazosin
US4565821A (en) * 1983-03-21 1986-01-21 The Texas A&M University System Method and ophthalmic composition for treating ocular hypertension and glaucoma with butyrophenones
IT1212742B (it) * 1983-05-17 1989-11-30 Dompe Farmaceutici Spa Derivati dibenzo [1,4]diazepinonici pirido [1,4] benzodiazepinonici,pirido [1,5] benzodiazepinonici e loro attivita' farmacologica
DE3409237A1 (de) * 1984-03-14 1985-09-19 Dr. Karl Thomae Gmbh, 7950 Biberach Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4886815A (en) * 1984-06-20 1989-12-12 Schachar Ronald A Treatment and prevention of retinal edema with dopaminergic antagonists
DE3626095A1 (de) * 1986-07-31 1988-02-11 Thomae Gmbh Dr K Neue substituierte pyrido(2,3-b)(1,4)benzodiazepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ATE147626T1 (de) * 1989-06-21 1997-02-15 Univ Pennsylvania Verwendung von pirenzepine, telenzepine oder o- methoxy -sila-hexocyclium zur herstellung eines medikaments zur behandlung und regulierung der augenentwicklung
US5066664A (en) * 1990-02-28 1991-11-19 Allergan, Inc. 2-(hydroxy-2-alkylphenylamino)-oxazolines and thiazolines as anti-glaucoma and vasoconstrictive agents
US5091528A (en) * 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
US5153205A (en) * 1990-10-01 1992-10-06 Merck & Co., Inc. Method to reduce introacular pressure without causing miosis

Also Published As

Publication number Publication date
US5716952A (en) 1998-02-10
AU3810993A (en) 1993-10-21
EP0634932B1 (de) 2002-06-19
JPH07504915A (ja) 1995-06-01
DE69332048D1 (de) 2002-07-25
DE69332048T2 (de) 2003-01-23
EP0634932A1 (de) 1995-01-25
AU666536B2 (en) 1996-02-15
WO1993018772A1 (en) 1993-09-30
ES2177543T3 (es) 2002-12-16

Similar Documents

Publication Publication Date Title
ATE219367T1 (de) Verfahren zur senkung des augeninnendrucks im auge von säugern unter anwendung von muskarinantagonisten
US6534496B1 (en) Thermogenic composition and benzazepine thermogenics
US5096890B1 (en) Pyrrolidine derivatives
ES8708224A1 (es) Un procedimiento para la preparacion de nuevos derivados de carbazolona
PT1638970E (pt) Derivados de pirid(2,1-a)isoquinolina como inibidores de dpp-iv
NO171109C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske spiroforbindelser
RO117851B1 (ro) Compusi spiranici si compozitie farmaceutica care ii contine
JP2002521429A5 (de)
US4592866A (en) Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof
ATE206398T1 (de) 1,3-substituierte cycloalkene und cycloalkane mit zentraler nervensystemwirkung
ATE213631T1 (de) Benzo- und pyridopyranderivate mit anxiolytischer und antikonvulsiver aktivität
US4735940A (en) Tricyclic pyridine derivatives and pharmaceutical compositions
DE69129165D1 (de) Prozess zur Darstellung von Lactamderivaten
CA2132007A1 (en) Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists
AR051595A1 (es) Composiciones farmaceuticas a base de nk2 antagonista para uso pediatrico
KR890011886A (ko) 축합된 디아제피논, 이의 제조방법 및 이를 함유하는 약제학적 조성물
RU99123631A (ru) Соли оптически активного сульфоксидного производного
TH34036A (th) วิธีสำหรับการควบคุมสูตรเครื่องหมาย trkA

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties